PMV Pharmaceuticals Inc
PMV Pharmaceuticals Inc Stock, NASDAQ:PMVP
PMV Pharmaceuticals, Inc. engages in the development of p53 targeted small molecule drugs for the treatment of cancer. It combines unique biological understanding with pharmaceutical development focus. The company was founded by Arnold J. Levine, David Henry Mac, and Thomas E. Shenk in 2013 and is headquartered in Cranbury, NY.